Skip to main content

Table 2 Characteristics of COPD patients referred for pulmonary rehabilitation with normal and low ASMI, after stratification into BMI categories

From: Frequency and functional translation of low muscle mass in overweight and obese patients with COPD

BMI group

Normal weight (n=205)

Overweight (n=156)

Obese (n=103)

ASMI group

Normal (n=25)

Low (n=180)

Normal (n=62)

Low (n=94)

Normal (n=87)

Low (n=16)

Subjects, % males

28.0

54.4*

53.2

63.8

55.1

56.2

Age, years

62 ± 9

64 ± 9

65 ± 10

66 ± 9

64 ± 9

63 ± 7

BMI, kg m-2

21.9 ± 1.9

21.9 ± 1.8

27.8 ± 1.5

27.0 ± 1.2#

33.5 ± 2.9

31.7 ± 2.1#

FFMI, kg m-2

16.3 [15.3–18.0]

15.3 [14.2–17.0]†

18.5 [16.5–19.6]

17.1 [15.7–18.3]#

20.1 [18.4–21.4]

18.0 [15.6–19.2]#

FEV1, l

1.34 [0.91–1.84]

0.98 [0.74–1.37]†

1.47 [0.96–2.01]

1.09 [0.77–1.57]†

1.49 [1.09–1.83

1.01 [0.66–1.60]†

FEV1, %pred

53.2 [43.4–67.1]

37.8 [29.1–52.1]#

59.8 [41.9–74.4]

42.4 [30.9–59.4]#

57.0 [44.6–68.8]

41.3 [27.3–54.5]†

FEV1/FVC, %

38.3 [32.1–43.3]

31.0 [25.4–40.8]#

43.4 [32.5–50.7]

32.6 [25.5–43.0]†

44.0 [36.6–52.7]

33.5 [28.1–41.3]†

TLCO, %pred

52.0 [41.5–69.7]

42.1 [33.4–50.0]†

52.0 [40.8–63.1]

47.0 [36.7–61.0]

57.1 [49.2–68.5]

42.0 [34.3–49.0]#

mMRC, % grade ≥ 2

56.0

83.8†

75.8

82.4

82.6

93.7

6MWD, m

523 ± 92

417 ± 123#

471 ± 110

391 ± 122#

426 ± 114

356 ± 97*

6MWD, %pred

81 ± 12

63 ± 18#

76 ± 15

64 ± 17#

71 ± 16

59 ± 15†

Wmax, W

84 [61–98]

55 [44–74]#

74 [58–100]

64 [46–78]†

74 [61–95]

54 [37–72]*

Wmax, %pred

69 [46–96]

45 [32–65]#

58 [48–84]

47 [37–64]#

58 [43–86]

45 [36–55]*

VO2max, ml m-1

1244 [880–1438]

888 [691–1034]#

1156 [900–1402]

1060 [873–1303]

1230 [995–1501]

958 [818–1147]*

VO2max, %pred

75 [51–102]

52 [37–72]#

67 [53–88]

56 [46–76]†

67 [55–97]

55 [46–70]

CWRT, s

285 [219–491]

206 [154–298]†

255 [187–360]

214 [175–314]

258 [172–461]

230 [172–304]

Quadriceps PT, Nm

90 ± 23

81 ± 29

139 ± 35

144 ± 29

113 ± 42

93 ± 29

Quadriceps PT, %pred

72 ± 18

58 ± 15#

76 ± 16

65 ± 17#

79 ± 18

64 ± 13*

SGRQ Total score, pts

55 [38–68]

63 [49–75]

58 [46–70]

65 [52–74]

65 [52–75]

66 [61–79]

HADS Anxiety score, pts

9 [3–11]

6 [4–11]

6 [5–12]

7 [5–11]

7 [5–11]

11 [5–13]*

HADS Depression score, pts

7 [4–11]

6 [3–10]

7 [4–10]

8 [4–11]

8 [4–10]

6 [4–14]

ASMI, kg m-2

6.39 ± 0.80

5.55 ± 0.79#

6.93 ± 0.86

6.07 ± 0.87#

7.53 ± 1.00

6.20 ± 0.76

Lumbar spine T-score

− 2.04 ± 1.60

− 1.05 ± 1.53†

− 0.88 ± 1.35

− 0.90 ± 1.67

− 0.74 ± 1.46

− 0.98 ± 1.41

Hip T-score

− 1.66 ± 0.99

− 1.75 ± 0.98

− 1.66 ± 0.89

− 1.70 ± 0.98

− 1.11 ± 1.03

− 1.41 ± 0.80

  1. Mean ± standard deviation, median [interquartile range 25–75%] or frequency reported. ASMI appendicular skeletal muscle mass index, BMI body mass index, FFMI fat-free mass index, FEV1 forced expiratory volume in the first second, FVC forced vital capacity, TLCO transfer factor for carbon monoxide, mMRC modified Medical Research Council, 6MWD six-minute walking distance, Wmax peak load during cycle ergometry, VO2max peak oxygen uptake during cycle ergometry, CWRT time during constant work rate test, PT peak torque, SGRQ St George’s Respiratory Questionnaire, HADS hospital anxiety and depression questionnaire, *P < 0.05 versus normal FFMI from the same BMI group. †P < 0.01 versus normal FFMI from the same BMI group. #P < 0.001 versus normal FFMI from the same BMI group